There is relatively little literature on dopamine and immune function in bipolar individuals, but studies examining patients diagnosed with schizophrenia, bipolar (Vogel et al., 2004), and psychosis (Marazziti et al., 2010) showed decreased Drd3 and DAT mRNA in PBLs. This evidence concerns the gene SLC6A3 and schizophrenia.